Dattatraya Patil

Emory University, Emory University Hospital

Papers

3

Total Citations

23

H-Index

2

About

Dr. Dattatraya Patil is a prominent urologic researcher whose work centers on health disparities, surgical outcomes, and the impact of healthcare policy on prostate cancer treatment. A key contribution is his investigation into how race, insurance coverage, and access to advanced technology affect treatment patterns for high-risk prostate cancer, a study that has garnered 19 citations and highlighted critical inequities in oncologic care. Dr. Patil is also a leading member of the Single Port Advanced Research Consortium (SPARC), where his 2025 propensity-matched analysis demonstrated the efficacy of single-port robotic retroperitoneal partial nephrectomy, advancing minimally invasive surgical techniques. His research further examines the consequences of Medicare payment policy changes, notably analyzing how reduced reimbursement for robotic prostatectomy influenced the use of urethral suspension procedures. By bridging clinical outcomes, surgical innovation, and health policy, Dr. Patil’s work provides essential insights for improving equitable access to advanced urologic care and shaping evidence-based practice.

Research Focus

Key Achievements

2
H-Index
3
Papers
23
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology
19 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 38
🏛 Institutions: Emory University, Emory University Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago